Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Read now
Stefano de Biase, Gian Luigi Gigli & Mariarosaria Valente. (2020) Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 853-863.
Read now
Read now
Anteneh M Feyissa. (2019) Brivaracetam in the treatment of epilepsy: a review of clinical trial data. Neuropsychiatric Disease and Treatment 15, pages 2587-2600.
Read now
Read now
Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente & Giovanni Merlino. (2019) Timing use of novel anti-epileptic drugs: is earlier better?. Expert Review of Neurotherapeutics 19:10, pages 945-954.
Read now
Read now
Articles from other publishers (7)
Kehui Xu, Manru Ning, Wenqi Li, Haijuan Dong, Yuting Lu, Taijun Hang & Min Song. (2023) Identification of degradation products of brivaracetam using liquid chromatography quadrupole time‐of‐flight tandem mass spectrometry: Degradation pathway elucidation. Rapid Communications in Mass Spectrometry 38:2.
Crossref
Crossref
Siyuan Guo, Baode Ma, Gen-Qiang Chen & Xumu Zhang. (2023) Stereodivergent Synthesis of Enantioenriched 2-Pyrrolidones via Diastereoselective Hydrogenation of α,β-Unsaturated γ-Lactams. Organic Letters 25:14, pages 2426-2431.
Crossref
Crossref
Jiacheng Feng, Yuting Xue, Jiayan Wang, Xiaoqiang Xie, Changxin Lu, Hanchi Chen, Yuele Lu, Linjiang Zhu, Dingjun Chu & Xiaolong Chen. (2023) Enhancing the asymmetric reduction activity of ene-reductases for the synthesis of a brivaracetam precursor. Process Biochemistry 126, pages 108-116.
Crossref
Crossref
Danielle S. Abraham, Thanh Phuong Pham Nguyen, Leah J. Blank, Dylan Thibault, Shelly L. Gray, Sean Hennessy, Charles E. Leonard, Daniel Weintraub & Allison W. Willis. (2023) Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies. Neurotherapeutics 20:2, pages 375-388.
Crossref
Crossref
Kuan‐Ying Li, Chung‐Yao Hsu & Yuan‐Han Yang. (2023) A review of cognitive and behavioral outcomes of Brivaracetam. The Kaohsiung Journal of Medical Sciences 39:2, pages 104-114.
Crossref
Crossref
Hongyi Yang, Leting Yang, Xiaofang Zhong, Xuehua Jiang, Liang Zheng & Ling Wang. (2022) Physiologically based pharmacokinetic modeling of brivaracetam and its interactions with rifampin based on CYP2C19 phenotypes. European Journal of Pharmaceutical Sciences 177, pages 106258.
Crossref
Crossref
Te-Yu Hung, Sheng-Nan Wu & Chin-Wei Huang. (2021) The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines 9:4, pages 369.
Crossref
Crossref